001051951 001__ 1051951
001051951 005__ 20260223122530.0
001051951 0247_ $$2doi$$a10.1152/ajpgi.00362.2024
001051951 0247_ $$2ISSN$$a0193-1857
001051951 0247_ $$2ISSN$$a1522-1547
001051951 0247_ $$2datacite_doi$$a10.34734/FZJ-2026-00632
001051951 0247_ $$2pmid$$a41071686
001051951 0247_ $$2WOS$$aWOS:001620711300001
001051951 037__ $$aFZJ-2026-00632
001051951 082__ $$a610
001051951 1001_ $$0P:(DE-HGF)0$$aAchilles, Sophie$$b0
001051951 245__ $$aN -glycans on SLC26A3 do not significantly alter plasma membrane or lipid raft trafficking, but appear to stabilize interdomain contacts to stimulate transport
001051951 260__ $$aBethesda, Md.$$bAmerican Physiological Society$$c2025
001051951 3367_ $$2DRIVER$$aarticle
001051951 3367_ $$2DataCite$$aOutput Types/Journal article
001051951 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1769162564_19119
001051951 3367_ $$2BibTeX$$aARTICLE
001051951 3367_ $$2ORCID$$aJOURNAL_ARTICLE
001051951 3367_ $$00$$2EndNote$$aJournal Article
001051951 500__ $$aThe mass spectrometric analysis of this project was supportedby funding from the German Research Foundation (ProjectNumber: 505943254) to S.O. This work was supported by theGerman Research Foundation as parts of the Research Unit FOR5046 (Project Number: 426950122) to J.-P.M. (Project P2), toE.R.G. (Project P1), and to I.W. and G.L. (Project P5). The authorsgratefully acknowledge computing time on the supercomputerJURECA (1) at Forschungszentrum J€ulich under Grant No.jara0177.
001051951 520__ $$aDRA (Downregulated in adenoma, SLC26A3) is a major apical intestinal Cl/HCO3 exchanger, which is expressed in complexand hybrid N-glycosylated forms. Although the importance of N-glycosylation is evident from the significantly reduced transportactivity of non-N-glycosylated DRA constructs (DRA-N0), the underlying molecular mechanisms are controversial. Therefore,plasma membrane expression and lipid raft localization of glycosylation-deficient DRA-N0 were analyzed in HEK cells. The activityof DRA-N0 was reduced by 70% compared with the wild-type construct. Absolute expression of DRA-N0 was significantlyreduced by 57% in the cell lysate and by 34 and 45% in the plasma membrane and in plasma membrane-derived lipid rafts,respectively. These amounts are insufficient to account for the reduction in activity. Furthermore, the statistical analysis did notsupport a difference in the relative expression of DRA and DRA-N0 in the plasma membrane and in plasma membrane-derivedlipid rafts, indicating that N-glycosylation does not affect transport activity through trafficking and localization in these cell compartments.To gain insight into potential intramolecular effects of N-glycosylation on DRA, its three-dimensional structure waspredicted using AlphaFold3 with complex N-glycans covalently attached to N153, N161, and N164 in the transport domain. Thisrevealed multiple inward- and outward-facing conformations of the protein. The number of interdomain contacts of the transportdomain-bound glycans with the scaffold domain was higher in the inward-facing state. Because substrate release to the cytoplasmrepresents the rate-limiting step in many transport proteins, this suggests that in DRA, glycans stabilize the inward-facingstate facilitating anion transport.NEW & NOTEWORTHY Deficient N-glycosylation decreases DRA transport activity but does not significantly affect trafficking tothe plasma membrane or to lipid rafts. Meanwhile, molecular modeling predicts stabilizing interdomain contacts of the glycans,covalently attached to the transport domain, with the scaffold domain having more contacts in the inward-facing state. Favoringthe inward-facing state may facilitate more efficacious anion transport, as substrate release from this state into the cytoplasm isa rate limiting step for numerous transport proteins.
001051951 536__ $$0G:(DE-HGF)POF4-5243$$a5243 - Information Processing in Distributed Systems (POF4-524)$$cPOF4-524$$fPOF IV$$x0
001051951 536__ $$0G:(GEPRIS)426950122$$aDFG project G:(GEPRIS)426950122 - FOR 5046: Integrative Analyse epithelialer SLC26 Anionentransporter – von der molekularen Struktur zur Pathophysiologie (426950122)$$c426950122$$x1
001051951 588__ $$aDataset connected to CrossRef, Journals: juser.fz-juelich.de
001051951 7001_ $$0P:(DE-HGF)0$$aTomczak, Jan-Niklas$$b1
001051951 7001_ $$0P:(DE-HGF)0$$aBaumann, Fabiane-Samira$$b2
001051951 7001_ $$0P:(DE-Juel1)189098$$aHaddad, Bassam G.$$b3$$ufzj
001051951 7001_ $$0P:(DE-HGF)0$$aOswald, Stefan$$b4
001051951 7001_ $$0P:(DE-Juel1)156429$$aMachtens, Jan-Philipp$$b5$$eCorresponding author
001051951 7001_ $$00000-0002-2789-5444$$aGeertsma, Eric R.$$b6$$eCorresponding author
001051951 7001_ $$0P:(DE-HGF)0$$aWittig, Ilka$$b7
001051951 7001_ $$00000-0003-0997-3135$$aLamprecht, Georg$$b8$$eCorresponding author
001051951 773__ $$0PERI:(DE-600)1477329-6$$a10.1152/ajpgi.00362.2024$$gVol. 329, no. 5, p. G628 - G638$$n5$$pG628 - G638$$tAmerican journal of physiology / Gastrointestinal and liver physiology$$v329$$x0193-1857$$y2025
001051951 8564_ $$uhttps://juser.fz-juelich.de/record/1051951/files/Amer_Journal_Physiology_Machtens_10_2025.pdf$$yOpenAccess
001051951 909CO $$ooai:juser.fz-juelich.de:1051951$$pdnbdelivery$$pdriver$$pVDB$$popen_access$$popenaire
001051951 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)189098$$aForschungszentrum Jülich$$b3$$kFZJ
001051951 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)156429$$aForschungszentrum Jülich$$b5$$kFZJ
001051951 9131_ $$0G:(DE-HGF)POF4-524$$1G:(DE-HGF)POF4-520$$2G:(DE-HGF)POF4-500$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$9G:(DE-HGF)POF4-5243$$aDE-HGF$$bKey Technologies$$lNatural, Artificial and Cognitive Information Processing$$vMolecular and Cellular Information Processing$$x0
001051951 9141_ $$y2025
001051951 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-14
001051951 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-14
001051951 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2024-12-14
001051951 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2024-12-14
001051951 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2024-12-14
001051951 915__ $$0LIC:(DE-HGF)CCBYNCND4$$2HGFVOC$$aCreative Commons Attribution-NonCommercial-NoDerivs CC BY-NC-ND 4.0
001051951 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bAM J PHYSIOL-GASTR L : 2022$$d2024-12-14
001051951 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2024-12-14
001051951 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2024-12-14
001051951 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-14
001051951 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2024-12-14
001051951 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
001051951 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2024-12-14
001051951 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2024-12-14
001051951 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2024-12-14$$wger
001051951 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-14
001051951 920__ $$lyes
001051951 9201_ $$0I:(DE-Juel1)IBI-1-20200312$$kIBI-1$$lMolekular- und Zellphysiologie$$x0
001051951 980__ $$ajournal
001051951 980__ $$aVDB
001051951 980__ $$aUNRESTRICTED
001051951 980__ $$aI:(DE-Juel1)IBI-1-20200312
001051951 9801_ $$aFullTexts